THR-β agonist 2
THR-β agonist 2 is a potent agonist of THR-β. THR-β agonist 2 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021121210A1, compound 3) [1].
Product Specifications
CAS Number
2440027-77-8
UNSPSC
12352005
Target
Thyroid Hormone Receptor
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/thr-β-agonist-2.html
Purity
99.31
Solubility
DMSO : 350 mg/mL (ultrasonic)
Smiles
N#CC1=NN(C2=CC(Cl)=C(OC3=NNC(C4=C3C=CC=C4)=O)C(Cl)=C2)C(NC1=O)=O
Molecular Formula
C18H8Cl2N6O4
Molecular Weight
443.20
References & Citations
[1]Fanglong Yang, et al. Heterocyclic derivatives, their preparation methods and their application in medicine. Patent WO2021121210A1.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Saccharomyces cerevisiae Uncharacterized protein YIL060W (YIL060W) , partial
Hbq1a sgRNA CRISPR Lentivector (Mouse) (Target 1)